AlzBiomarker
Alzheimer's Disease vs Control: GFAP (Plasma and Serum)
Meta-analysis of seven comparisons revealed that blood (plasma or serum) levels of the astrocytic marker glial fibrillary acid protein (GFAP) in people with Alzheimer's disease is nearly double that of control subjects (effect size = 1.928, p <0.0001).
Loading data...